10-Q Filing

BENITEC BIOPHARMA INC. CIK: 1808898 Q1 2023

Filing Information

Form Type	10-Q
Accession Number	`0001193125-22-281978`
Period End Date	20220930
Filing Date	20221110
Fiscal Year	2023
Fiscal Period	Q1
XBRL Instance	d416162d10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 56 Income Statement 36 Cash Flow Statement 37 Stockholders Equity 16

Balance Sheet 56 line items

Line Item	Tag	Value	Unit	Period
Common Stock Par Value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock Par Value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock Shares Authorized	`CommonStockSharesAuthorized`	40.00M	shares	Point-in-time
Common Stock Shares Authorized	`CommonStockSharesAuthorized`	40.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$16.53M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.06M	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	25.81M	shares	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	8.17M	shares	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	25.81M	shares	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$13.00K	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$14.00K	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	8.17M	shares	Point-in-time
Trade and other receivables	`AccountsAndOtherReceivablesNetCurrent`	$3.00K	USD	Point-in-time
Trade and other receivables	`AccountsAndOtherReceivablesNetCurrent`	$3.00K	USD	Point-in-time
Prepaid and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$531.00K	USD	Point-in-time
Prepaid and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$741.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.82M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$17.08M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$179.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$222.00K	USD	Point-in-time
Deposits	`DepositAssets`	$25.00K	USD	Point-in-time
Deposits	`DepositAssets`	$25.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$119.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$135.00K	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$711.00K	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$771.00K	USD	Point-in-time
Total assets	`Assets`	$18.11M	USD	Point-in-time
Total assets	`Assets`	$5.97M	USD	Point-in-time
Trade and other payables	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$1.88M	USD	Point-in-time
Trade and other payables	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$2.37M	USD	Point-in-time
Accrued employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$400.00K	USD	Point-in-time
Accrued employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$385.00K	USD	Point-in-time
Lease liabilities, current portion	`OperatingLeaseLiabilityCurrent`	$252.00K	USD	Point-in-time
Lease liabilities, current portion	`OperatingLeaseLiabilityCurrent`	$258.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.53M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.01M	USD	Point-in-time
Lease liabilities, less current portion	`OperatingLeaseLiabilityNoncurrent`	$491.00K	USD	Point-in-time
Lease liabilities, less current portion	`OperatingLeaseLiabilityNoncurrent`	$559.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$3.09M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.50M	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.0001 par value-40,000,000 shares authorized; 25,809,533 shares and 8,171,690 shares issued and outstanding at September 30, 2022 and June 30, 2022, respectively	`CommonStockValue`	$1.00K	USD	Point-in-time
Common stock, $0.0001 par value-40,000,000 shares authorized; 25,809,533 shares and 8,171,690 shares issued and outstanding at September 30, 2022 and June 30, 2022, respectively	`CommonStockValue`	$3.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$152.45M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$168.77M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-153.42M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-148.33M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-738.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.25M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$14.61M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$2.88M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$20.01M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$15.47M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$18.11M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$5.97M	USD	Point-in-time

Income Statement 36 line items

Line Item	Tag	Value	Unit	Period
Licensing revenues from customers	`RevenueFromContractWithCustomerIncludingAssessedTax`	-	USD	1 Quarter
Licensing revenues from customers	`RevenueFromContractWithCustomerIncludingAssessedTax`	-	USD	1 Quarter
Total revenues	`Revenues`	-	USD	1 Quarter
Total revenues	`Revenues`	-	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.66M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.78M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.04M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.92M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$4.58M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$4.82M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-4.82M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-4.58M	USD	1 Quarter
Foreign currency transaction loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-507.00K	USD	1 Quarter
Foreign currency transaction loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-240.00K	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-1.00K	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-9.00K	USD	1 Quarter
Unrealized gain on investment	`UnrealizedGainLossOnInvestments`	$3.00K	USD	1 Quarter
Unrealized gain on investment	`UnrealizedGainLossOnInvestments`	$18.00K	USD	1 Quarter
Total other income (loss), net	`NonoperatingIncomeExpense`	$-223.00K	USD	1 Quarter
Total other income (loss), net	`NonoperatingIncomeExpense`	$-513.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.09M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.04M	USD	1 Quarter
Unrealized foreign currency translation gain	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$507.00K	USD	1 Quarter
Unrealized foreign currency translation gain	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$239.00K	USD	1 Quarter
Total other comprehensive income	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$239.00K	USD	1 Quarter
Total other comprehensive income	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$507.00K	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-4.81M	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-4.59M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.47	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.62	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.62	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.47	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	10.86M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	8.17M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	8.17M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	10.86M	shares	1 Quarter

Cash Flow Statement 37 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-5.09M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.04M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$42.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$52.00K	USD	1 Quarter
Amortization of right-of-use assets	`AmortizationOfRightOfUseAssets`	$50.00K	USD	1 Quarter
Amortization of right-of-use assets	`AmortizationOfRightOfUseAssets`	$60.00K	USD	1 Quarter
Unrealized gain on investment	`UnrealizedGainLossOnInvestments`	$3.00K	USD	1 Quarter
Unrealized gain on investment	`UnrealizedGainLossOnInvestments`	$18.00K	USD	1 Quarter
Share-based compensation expense	`ShareBasedCompensation`	$302.00K	USD	1 Quarter
Share-based compensation expense	`ShareBasedCompensation`	$271.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-179.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-220.00K	USD	1 Quarter
Trade and other payables	`IncreasedecreaseInAccountsAndOtherPayables`	$500.00K	USD	1 Quarter
Trade and other payables	`IncreasedecreaseInAccountsAndOtherPayables`	$293.00K	USD	1 Quarter
Accrued employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-8.00K	USD	1 Quarter
Accrued employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-11.00K	USD	1 Quarter
Lease liabilities	`IncreaseDecreaseInLeaseLiabilities`	$-62.00K	USD	1 Quarter
Lease liabilities	`IncreaseDecreaseInLeaseLiabilities`	$-52.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.04M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.28M	USD	1 Quarter
Proceeds from issuance of common stock, pre-funded warrants, and common warrants	`ProceedsFromIssuanceOfCommonStockPreFundedWarrantsAndCommonWarrants`	$17.88M	USD	1 Quarter
Shares and pre-funded warrant issuance costs	`PaymentsOfStockIssuanceCosts`	$1.87M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$16.02M	USD	1 Quarter
Effects of exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$236.00K	USD	1 Quarter
Effects of exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$501.00K	USD	1 Quarter
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$12.47M	USD	1 Quarter
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-4.04M	USD	1 Quarter
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$15.74M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.08M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.78M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$16.55M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$15.74M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.08M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.78M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$16.55M	USD	Point-in-time
Re-measurement of operating lease right-of-use assets and liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	1 Quarter
Re-measurement of operating lease right-of-use assets and liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$794.00K	USD	1 Quarter

Stockholders Equity 16 line items

Line Item	Tag	Value	Unit	Period
Payments For Stock Issuance Costs	`PaymentsOfStockIssuanceCosts`	$1.87M	USD	1 Quarter
Balance at the beginning	`StockholdersEquity`	$14.61M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$2.88M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$20.01M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$15.47M	USD	Point-in-time
Issuance of common stock, pre-funded warrants, and common warrants sold for cash, net of offering costs of $1,869	`IssuanceAndExerciseOfPrefundedAndCommonWarrantsNetOfTransactionCosts`	$16.02M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$302.00K	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$271.00K	USD	1 Quarter
Foreign currency translation gain	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$507.00K	USD	1 Quarter
Foreign currency translation gain	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$239.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.09M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.04M	USD	1 Quarter
Balance at end	`StockholdersEquity`	$14.61M	USD	Point-in-time
Balance at end	`StockholdersEquity`	$2.88M	USD	Point-in-time
Balance at end	`StockholdersEquity`	$20.01M	USD	Point-in-time
Balance at end	`StockholdersEquity`	$15.47M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.